Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 6781 AL 6795

The novel function of bexarotene for neurological diseases

Liu Y, Wang P, Jin G, Shi P, Zhao Y, Guo J, Yin Y, Shao Q, Li P, Yang P.

Ageing Res Rev. 2023 Sep;90:102021. doi: 10.1016/j.arr.2023.102021. Epub 2023 Jul 24.

The Neuropharmacological Evaluation of Seaweed: A Potential Therapeutic Source

Jannat K, Balakrishnan R, Han JH, Yu YJ, Kim GW, Choi DK.

Cells. 2023 Nov 18;12(22):2652. doi: 10.3390/cells12222652.

Impact of TRPV1 on Pathogenesis and Therapy of Neurodegenerative Diseases

Wang W, Sun T.

Molecules. 2023 Dec 28;29(1):181. doi: 10.3390/molecules29010181.

Targeting the central nervous system: From synthetic nanoparticles to extracellular vesicles-Focus on Alzheimer's and Parkinson's disease

Hernando S, Santos-Vizcaíno E, Igartua M, Hernandez RM.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Sep-Oct;15(5):e1898. doi: 10.1002/wnan.1898. Epub 2023 May 8.

Traversing through the cell signaling pathways of neuroprotection by betanin: therapeutic relevance to Alzheimer's Disease and Parkinson's Disease

Phukan BC, Roy R, Paul R, Mazumder MK, Nath J, Bhattacharya P, Borah A.

Metab Brain Dis. 2023 Mar;38(3):805-817. doi: 10.1007/s11011-023-01177-8. Epub 2023 Feb 6.

Pharmacological and Pathological Relevance of S100 Proteins in Neurological Disorders

Goswami D, Anuradha U, Angati A, Kumari N, Singh RK.

CNS Neurol Disord Drug Targets. 2023;22(10):1403-1416. doi: 10.2174/1871527322666221128160653.

Anti-amyloid potential of some phytochemicals against Aβ-peptide and α-synuclein, tau, prion, and Huntingtin protein

Jerom JP, Madhukumar S, Nair RH, Narayanan SP.

Drug Discov Today. 2023 Dec;28(12):103802. doi: 10.1016/j.drudis.2023.103802. Epub 2023 Oct 17.

LRRK2 and Parkinson's disease: from genetics to targeted therapy

Sosero YL, Gan-Or Z.

Ann Clin Transl Neurol. 2023 Jun;10(6):850-864. doi: 10.1002/acn3.51776. Epub 2023 Apr 6.

Nanoparticle Mediated Gene Therapy: A Trailblazer Armament to Fight CNS Disorders

Annu, Rehman S, Nabi B, Sartaj A, Md S, Sahoo PK, Baboota S, Ali J.

Curr Med Chem. 2023;30(3):304-315. doi: 10.2174/0929867329666220105122318.

Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions

Koerich S, Parreira GM, de Almeida DL, Vieira RP, de Oliveira ACP.

Curr Neuropharmacol. 2023;21(2):219-234. doi: 10.2174/1570159X20666220922153903.

Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease

Nowell J, Blunt E, Gupta D, Edison P.

Ageing Res Rev. 2023 Aug;89:101979. doi: 10.1016/j.arr.2023.101979. Epub 2023 Jun 14.

Natural Products as Bioactive Agents in the Prevention of Dementia

Ullah H, Hussain A, Asif M, Nawaz F, Rasool M.

CNS Neurol Disord Drug Targets. 2023;22(4):466-476. doi: 10.2174/1871527321666220422085835.

Defective lysosomal acidification: a new prognostic marker and therapeutic target for neurodegenerative diseases

Lo CH, Zeng J.

Transl Neurodegener. 2023 Jun 8;12(1):29. doi: 10.1186/s40035-023-00362-0.

Anti-Inflammatory Effects of Flavonoids in Common Neurological Disorders Associated with Aging

Martínez-Coria H, Arrieta-Cruz I, Gutiérrez-Juárez R, López-Valdés HE.

Int J Mol Sci. 2023 Feb 21;24(5):4297. doi: 10.3390/ijms24054297.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias